{"id":"W4206819073","doi":"10.1200/jco.2021.39.15_suppl.5545","title":"Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION primary analysis.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Medicine; Internal medicine; Clinical endpoint; Progression-free survival; Ovarian cancer; Oncology; Progressive disease; Phases of clinical research; BRCA mutation; Placebo; Cancer; Chemotherapy; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001233395,0.0006635655,0.001177757,0.0002814911,0.0002335893,0.0008423738,0.0005523451,0.0008262682,0.008012339],"category_scores_gemma":[0.001013414,0.0004112733,0.001155842,0.0004689517,0.0003614034,0.0006158022,0.000290178,0.00153746,0.001148951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008346615,"about_ca_system_score_gemma":0.0009664053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008579068,"about_ca_topic_score_gemma":0.003136735,"domain_scores_codex":[0.9996941,0.0001484691,0.00001866039,0.00006239093,0.00003343009,0.00004285077],"domain_scores_gemma":[0.9994668,0.0001005726,0.0001714378,0.00004896693,0.00004363873,0.0001686118],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7987089,0.01922926,0.01540021,0.00345305,0.003796899,0.0002855044,0.0002012802,0.001482728,0.02400408,0.0005108093,0.01506155,0.1178657],"study_design_scores_gemma":[0.7856545,0.1730535,0.02475568,0.0001818509,0.002264387,0.000724108,0.00006964216,0.0009299132,0.002123768,0.0005812019,0.009629289,0.00003219225],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9570467,0.009961813,0.00140517,0.0011922,0.0001652969,0.009347718,0.0139763,0.0001387271,0.006765994],"genre_scores_gemma":[0.9667557,0.005133274,0.002670321,0.002042028,0.0002307251,0.006627352,0.01242473,0.00006147703,0.004054395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008012339,"threshold_uncertainty_score":0.02680391,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08132424089107043,"score_gpt":0.4716147225033498,"score_spread":0.3902904816122794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}